home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Illumina, Inc. - Common Stock (NQ:ILMN)

141.13 -3.68 (-2.54%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

36 37 Next >

Illumina's CEO Was Just Ousted: Should Investors Buy In Now or Steer Clear? ↗

June 20, 2023

Things aren't looking up just yet.

Via The Motley Fool

How to Retire Rich: Biotech Stocks Edition ↗

June 18, 2023

Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.

Via InvestorPlace

3 Gene Testing Stocks to Buy Before They Take Off ↗

June 17, 2023

The future of gene testing is bright thanks to an aging population. Here are three companies leading the industry.

Via InvestorPlace

Illumina CEO Steps Down; Grail Soap Opera Continues ↗

June 16, 2023

And we interview Anjay Nagpal, host of the podcast "Brokers, Bagmen, and Moles."

Via The Motley Fool

Nephroblastoma Pipeline, NDA Approvals, Clinical Trials, and Emerging Drugs (2023) | Companies – Clarity Pharma, Y mAbs Therapeutics, Nova Biopharma, Eli Lilly, Illumina Radiopharma, Recombio and Other

June 16, 2023

Via AB Newswire

Ominous Death Cross Forms On Illumina's Chart ↗

June 15, 2023

Via Benzinga

Expert Ratings for Illumina ↗

June 12, 2023

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today ↗

June 06, 2023

Via Benzinga

Check Out What Whales Are Doing With ILMN ↗

May 25, 2023

Via Benzinga

Illumina's Grail Acquisition Gains Support from GOP Lawmakers and Advocacy Groups Despite FTC Resistance ↗

June 14, 2023

Republican lawmakers, state attorneys general, and several advocacy groups have expressed their support for Illumina Inc's (NASDAQ: ILMN) acquisition of Grail Inc, even as the Federal Trade Commission...

Via Benzinga

Is CEO Resignation a Sign That Carl Icahn Can Save Illumina (ILMN) Stock? ↗

June 12, 2023

The CEO of Illumina has stepped down due to pressure form Carl Icahn. ILMN stock has already started rising on the news.

Via InvestorPlace

Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories ↗

June 12, 2023

Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger

Via Benzinga

Executive Shakeup at Illumina: CEO Francis deSouza Steps Down Amid Activist Investor Carl Icahn's Pressure ↗

June 12, 2023

Illumina Inc (NASDAQ.

Via Benzinga

Nasdaq, S&P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low ↗

June 12, 2023

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today ↗

May 22, 2023

Via Benzinga

Illumina Unusual Options Activity ↗

May 18, 2023

Via Benzinga

Apple's Upcoming VR Headset Marks Significant New Product Debut In Almost 10 Years, Regulators Want Tighter Capital Requirements For Large US Banks, Software Configuration Error at Grail Causes Cancer Misdiagnosis: Today's Top Stories ↗

June 05, 2023

Wall Street Journal

Via Benzinga

Software Configuration Error at Grail Causes Cancer Misdiagnosis Scare; Could It Impact Illumina's Acquisition Plans? ↗

June 05, 2023

Illumina Inc's (NASDAQ: ILMN) Grail Inc acquisition is reportedly in more hot water when Grail mistakenly sent form letters to 400 patients, suggesting they may have developed cancer.

Via Benzinga

The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree ↗

June 02, 2023

Big Pharma is facing a patent cliff that could siphon off billions in revenue.

Via Investor's Business Daily

Carl Icahn Buys The Dip Amidst Hindenburg's Short Report ↗

May 16, 2023

Via Benzinga

Illumina's Debt Overview ↗

May 16, 2023

Via Benzinga

Peering Into Illumina's Recent Short Interest ↗

May 12, 2023

Via Benzinga

Illumina Unusual Options Activity ↗

May 10, 2023

Via Benzinga

Elon Musk Praises Quality of Made in China Teslas, Exxon Eyes Double Output With New Fracking Tech, Netflix Shareholders Vote Against Fat Exec. Pay: Today's Top Stories ↗

June 02, 2023

Benzinga

Via Benzinga

Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction ↗

June 02, 2023

Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 25, 2023

Via Benzinga

Bill Ackman Thinks Rival Icahn's Firm Still Overvalued, Nvidia Nears $1 Trillion Market Cap, Freshpet's Largest Shareholder Pushes For Board Overhaul: Today's Top Stories ↗

May 25, 2023

Benzinga

Via Benzinga

Carl Icahn's Power Play at Illumina: Potential Board Changes and Management Overhaul ↗

May 25, 2023

According to undisclosed sources, activist investor Carl Icahn is poised to secure enough shareholder support to place Andrew Teno, an Icahn nominee, to join the board of Illumina Inc (NASDAQ: ILMN).

Via Benzinga

IEP Stock Alert: Regulators Request Information From Icahn Enterprises ↗

May 10, 2023

Icahn Enterprises suffered sharply related to the earlier short-seller attack, sending IEP stock down as it feels the heat of “activism.”

Via InvestorPlace

Hestia Insight Inc. Signs Letter of Intent With Major Asian-Pacific Health Care Products Distributor

May 10, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Intellectual Property

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

36 37 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com